# Study to Explore the Effect of Dapagliflozin and Stress in Adolescent and Adult Subjects With Type 1 Diabetes (T1D)

> **NCT04234867** · PHASE1 · TERMINATED · sponsor: **Kinderkrankenhaus auf der Bult** · enrollment: 2 (actual)

## Conditions studied

- Type 1 Diabetes
- Diabetic Ketoacidosis

## Interventions

- **DRUG:** Dapagliflozin
- **DRUG:** Placebo oral tablet
- **OTHER:** Stress
- **OTHER:** Placebo Stress

## Key facts

- **NCT ID:** NCT04234867
- **Lead sponsor:** Kinderkrankenhaus auf der Bult
- **Sponsor class:** OTHER
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** TERMINATED
- **Start date:** 2022-05-18
- **Primary completion:** 2022-08-26
- **Final completion:** 2022-08-26
- **Target enrollment:** 2 (ACTUAL)
- **Why stopped:** slow recruitment
- **Last updated:** 2024-12-09


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04234867

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04234867, "Study to Explore the Effect of Dapagliflozin and Stress in Adolescent and Adult Subjects With Type 1 Diabetes (T1D)". Retrieved via AI Analytics 2026-06-08 from https://api.ai-analytics.org/clinical/NCT04234867. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*